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Introduction: Periprosthetic joint infection (PJI) is a major complication after total knee arthroscopy. Entero
bacter is a rare cause of PJI.
Case presentation: We present a 65 year old Caucasian man who presented with acute right knee PJI with
Carbapenem-resistant Enterobacteriaceae (CRE) two months after undergoing right knee intra-articular mass
removal with endoprosthetic reconstruction. The periprosthetic joint infection (PJI) was treated with revision
with 1-stage static spacer and IV meropenem.
Discussion: CRE is an uncommon cause of PJI, but when it does occur, it commonly infects patients who are
immunosuppressed or have specific risk factors. For an immunocompetent patient with CRE PJI, we suggest
further workup for other systemic disease.
Conclusion: This case demonstrates the importance of early diagnosis and treatment of CRE joint infections and
the need for a multidisciplinary approach that includes aggressive surgical intervention and tailored antimi
crobial therapy.

1. Introduction
Periprosthetic joint infection (PJI) is a severe complication after joint
arthroplasty that is associated with revision surgeries, prolonged hos
pitalization, and poor outcome [1]. Enterobacteriaceae, ubiquitous
gram-negative microorganism found in soil, water, and plants, are part
of the intestinal flora in humans. Primary joint infections caused by
E. cloacae, especially the carbapenem resistant types, are relatively rare
but common in the hospital setting in immunocompromised patients
and are increasing in incidence due to insurgence of the antibiotic
resistance [2].
E. cloacae are uncommonly reported as a cause of septic arthritis and
the involvement of a prosthetic joint represents a rare event. This is the
first case of PJI with E.cloacae in an immunocompetent patient without
recent bowel instrumentation reported in the literature. We present a
case of periprosthetic joint infection (PJI) in an individual who under
went primary right knee arthroscopy after intraarticular tumor removal.
Further infectious workup revealed markedly elevated serum C-reactive
protein (CRP) and knee culture positive for Carbapenem-resistant
Enterobacter cloacae (CRE). He underwent prosthesis explantation,

debridement, and placement of an antimicrobial mixed spacer.
This work has been reported in line with the SCARE 2020 criteria
[9].
2. Case Presentation
A 65 year-old patient with a history of longstanding pain, degener
ation and slow-growing nodules of the right knee presented to the
emergency department on January 2022 with a sudden increase in pain
that rendered him unable to function or ambulate. Past surgical history
includes esophageal repair in 2009. Family history was noncontributory.
Magnetic Resonance (MR) imaging of the right lower extremity
(RLE) demonstrated high-grade tricompartmental chondromalacia,
excessive synovial osteochondromatosis within the lateral suprapatellar
bursa with calcified masses measuring 5.3 cm and 3.7 cm (Fig. 1).
Notably, there were three large fluid collections measuring up to 15 cm
in the craniocaudal dimension as well as 6 cm in the AP and transverse
dimensions. Right knee mass removal, synovectomy, and an uncompli
cated reconstruction with endoprosthesis was performed (see Fig. 2).
On March 2022, the patient was readmitted for a 7-day history of
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worsening burning pain, warmth and swelling of his RLE and right knee.
Patient denied fevers, chills, dizziness, chest pain, shortness of breath.
On physical exam, two 4cm masses were palpated at the anteromedial
leg, RLE nonpitting edema and an area of fluctuance and tenderness to
palpation inferior to knee were noted. Preoperative Knee radiography
demonstrates loosening of hardware. The right knee was tender and had
decreased range of motion. Sensation was intact distally. CRP was
elevated at 11.2. Bedside ultrasound of the fluctuant mass revealed
loculations and cobblestoning, consistent with infectious etiology. There
was concern that this loculated cyst was communicating with joint fluid.
Intravenous meropenem was administered and right knee revision with
inclusion of a static spacer was performed.
The operation was performed by an orthopedic oncology surgeon
and began with an incision into joint space with immediate expulsion of
purulent material. Five deep tissue cultures with separate rongeurs were
extracted as specimens. Extensive debridement and synovectomy of all
diseased tissue was carried out. The distal femur removal step involving
freeing the stem proximally was a lengthy process, complicated by an
episode of significant bone bleeding. Hemostasis was achieved with
sterile tourniquet. For the tibial component, the cement mantle was
removed circumferentially and distally. The wound was irrigated with 3
L of bacitracin-infused saline. The spacers were prepared with cement
mixed with 3 g of vancomycin and 2.4 of gentamicin and fitted between
the femur and tibia. Fluoroscopy was used to confirm proper placement
and satisfactory alignment. A 19 Blake drain was placed prior to closure
and the arthrotomy was approximated with interrupted sutures. The
distal incisions were left open to drain. Intraoperative synovial fluid
cultures tested positive for Carbapenem-resistant Enterobacteriaceae
(CRE). The patient was continued on meropenem 1 g bolus intrave
nously over 2 hours, followed by 1 g every 6 hours. The postoperative
course was uncomplicated. Over the next month, follow-up in the
inpatient rehabilitation unit demonstrated continuous clinical im
provements with regressive pain, healed surgical wounds, without signs
of persistent infection.
At two months, patient underwent second-stage revision to rotating
platform hinge distal femur replacement. At 10-week postoperative
exam, patient was without signs of infection. The medical plan was for
suppression on levoquin and ambulation pain-free without assistive
devices with active ROM 10-100. During admission for reimplantation
he was noted by infectious disease specialist to have a subcutaneous 2
cm mass on his upper back which was incised and found to be purulent.
He was treated with IV antibiotics for two weeks for this before sup
pression continued. CRE is thought to be the source of his original
infection, as he noted it being there for possibly years, which would
explain his atypical species.

Fig. 2. Preoperative Anteroposterior and Lateral radiographic views of
knee prosthesis.

3. Discussion
PJI occurs in about 2% of primary total knee arthroplasty (TKA) [3].
Approximately 50% of PJIs are caused by Staphylococcus aureus or
coagulase-negative Staphylococcus epidermidis. Gram-negative bacte
ria such as the Enterobacteriaceae family are the cause of infection in
3–6% of the cases and are rather uncommon. Microbial contamination
of the prosthesis can occur during the operation through airborne
contamination or direct inoculation during the handling of the pros
thesis intraoperatively [2]. Virulence factors in Enterobacteriaceae
including adhesins and biofilm formation are major contributors to
prosthetic infections. Biofilm is broadly defined as a structured com
munity of microorganisms enclosed in a self-produced matrix, which
serve to enhance the bacterial survival inside patients, increasing the
probability of causing nosocomial infection [4].
Postoperatively, microbial seeding may occur through hematoge
nous spread or from contact by an adjacent septic source. One similar
reported case was of a 61-year-old immunocompetent man who devel
oped Enterobacter PJI four weeks after a bilateral total knee arthro
plasty. The most likely route of the infection was hematogenous seeding
of enteric bacteria due to an anastomotic leak after a bariatric surgery
done six months before the TKA [5]. For our case, it remains unclear
how E. cloacae infected the prosthesis of an immunocompetent man who
denied history of penetrating trauma or recent abdominal surgery. Im
aging before the revision operation revealed severe right knee chon
dromatosis, reservoirs of excess static joint fluid which, if
communicating with surrounding structures, can serve as nidus for
infection. It may be beneficial to pursue further diagnostic testing for

Fig. 1. Preoperative MR Images of right lower extremity and knee before total knee arthroplasty. (A) T1 Sagittal view, heterogenous masses communicating with
joint space. (B) T2 sagittal view, RLE multiple homogenous cysts. (C) T2 coronal view, heterogenous mass above lateral femoral condyle and cyst abutting proximal
tibia. (D) T2 axial view, homogenous cyst abutting proximal tibia.
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such patients to identify possible underlying systemic disease or
nonobvious viscus leakage permitting entrance of enteric bacteria into
bloodstream.
The diagnosis of PJIs can be challenging and is frequently made
through indirect measurements of inflammatory markers, joint fluid cell
counts and microbiology cultures [6]. The American Academy of Or
thopedic Surgeons developed a clinical practice guideline [7] for the
assessment of PJI, which include first screening patients who are found
to have the potential for PJI with erythrocyte sedimentation rate (ESR)
and C-reactive protein (CRP). When one or more inflammatory markers
are elevated, an aspiration of the knee to be sent for microbiologic
culture and differential white blood cell (WBC) count is then recom
mended. Prompt diagnosis of knee PJI is crucial to timely surgical
intervention. The acute presentation in this report was the main factor
influencing the decision to proceed with expedient irrigation and
debridement with a one-stage revision.
Treatment algorithms for PJI differ between acute and chronic in
fections. A two-stage revision is nearly always indicated chronic in
fections, which involves removal of all hardware, insertion of an
antibiotic-loaded dynamic or static spacer, a 6-week course of intrave
nous (IV) antibiotics, and reimplantation of the joint replacement once
the infection is proven eradicated [8] For an acute infection such as the
case we described, with symptoms less than three weeks duration, a
one-stage revision or irrigation and debridement with retention of
hardware is often attempted [8]. There are no established guidelines for
the pharmacologic treatment of CRE periprosthetic joint arthritis. Care
must be exercised when diagnosing, treating, and preventing CRE as
these species of bacteria use diverse moieties to degrade conventional
antibiotics. For antibiotic selection, our institution chose meropenem
monotherapy with careful monitoring of disease progression and
emerging resistance. We suggest that for any periprosthetic infection
involving multi-drug resistant species, infectious disease specialist and
microbiologist should be consulted as plans should be driven by in vitro
susceptibility testing.

publication of this case report and accompanying images. A copy of the
written consent is available for review by the Editor-in-Chief of this
journal on request.
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To our knowledge, this is the first documented case of Enterobacter
CRE knee PJI in an immunocompetent patient, with no apparent risk
factors such as trauma, diabetes, intravenous substance abuse, malig
nancy, or immunosuppression. This case highlights the importance of
recognizing relevant clinical features and subclinical inflammatory
markers to suspect PJI and direct appropriate surgical management.
Since Enterobacter PJI occurs more commonly in those who are
immunosuppressed, this diagnosis may prompt further workup for other
systemic disease. More studies are needed to understand the patho
genesis, role of biofilm, and optimal antibiotic management for
carbapenem-resistant microbes in the setting of prosthetic joint
infections.
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